The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ciclopirox Olamine Market Research Report 2024
Synopsis
Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.
The global Ciclopirox Olamine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ciclopirox Olamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ciclopirox Olamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ciclopirox Olamine in Ringworm Of The Body is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ciclopirox Olamine include Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, Preferred Pharmaceuticals, Ingenus Pharmaceuticals, Alvogen (CVC Capital Partners and Temasek ) and Acella Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ciclopirox Olamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclopirox Olamine.
Report Scope
The Ciclopirox Olamine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclopirox Olamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclopirox Olamine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc's Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Segment by Type
Cream Preparation
Temperture
Vaginal Suppository
Segment by Application
Ringworm Of The Body
Athlete'S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ciclopirox Olamine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.
The global Ciclopirox Olamine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ciclopirox Olamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ciclopirox Olamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ciclopirox Olamine in Ringworm Of The Body is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ciclopirox Olamine include Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, Preferred Pharmaceuticals, Ingenus Pharmaceuticals, Alvogen (CVC Capital Partners and Temasek ) and Acella Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ciclopirox Olamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclopirox Olamine.
Report Scope
The Ciclopirox Olamine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclopirox Olamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclopirox Olamine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc's Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Segment by Type
Cream Preparation
Temperture
Vaginal Suppository
Segment by Application
Ringworm Of The Body
Athlete'S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ciclopirox Olamine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ciclopirox Olamine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cream Preparation
1.2.3 Temperture
1.2.4 Vaginal Suppository
1.3 Market by Application
1.3.1 Global Ciclopirox Olamine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Ringworm Of The Body
1.3.3 Athlete'S Foot
1.3.4 Tinea
1.3.5 Tinea Versicolor
1.3.6 Candida Albicans
1.3.7 Gynecological Anti-Infection Preparation
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ciclopirox Olamine Market Perspective (2019-2030)
2.2 Ciclopirox Olamine Growth Trends by Region
2.2.1 Global Ciclopirox Olamine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ciclopirox Olamine Historic Market Size by Region (2019-2024)
2.2.3 Ciclopirox Olamine Forecasted Market Size by Region (2025-2030)
2.3 Ciclopirox Olamine Market Dynamics
2.3.1 Ciclopirox Olamine Industry Trends
2.3.2 Ciclopirox Olamine Market Drivers
2.3.3 Ciclopirox Olamine Market Challenges
2.3.4 Ciclopirox Olamine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ciclopirox Olamine Players by Revenue
3.1.1 Global Top Ciclopirox Olamine Players by Revenue (2019-2024)
3.1.2 Global Ciclopirox Olamine Revenue Market Share by Players (2019-2024)
3.2 Global Ciclopirox Olamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ciclopirox Olamine Revenue
3.4 Global Ciclopirox Olamine Market Concentration Ratio
3.4.1 Global Ciclopirox Olamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ciclopirox Olamine Revenue in 2023
3.5 Ciclopirox Olamine Key Players Head office and Area Served
3.6 Key Players Ciclopirox Olamine Product Solution and Service
3.7 Date of Enter into Ciclopirox Olamine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ciclopirox Olamine Breakdown Data by Type
4.1 Global Ciclopirox Olamine Historic Market Size by Type (2019-2024)
4.2 Global Ciclopirox Olamine Forecasted Market Size by Type (2025-2030)
5 Ciclopirox Olamine Breakdown Data by Application
5.1 Global Ciclopirox Olamine Historic Market Size by Application (2019-2024)
5.2 Global Ciclopirox Olamine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ciclopirox Olamine Market Size (2019-2030)
6.2 North America Ciclopirox Olamine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ciclopirox Olamine Market Size by Country (2019-2024)
6.4 North America Ciclopirox Olamine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ciclopirox Olamine Market Size (2019-2030)
7.2 Europe Ciclopirox Olamine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ciclopirox Olamine Market Size by Country (2019-2024)
7.4 Europe Ciclopirox Olamine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ciclopirox Olamine Market Size (2019-2030)
8.2 Asia-Pacific Ciclopirox Olamine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ciclopirox Olamine Market Size by Region (2019-2024)
8.4 Asia-Pacific Ciclopirox Olamine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ciclopirox Olamine Market Size (2019-2030)
9.2 Latin America Ciclopirox Olamine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ciclopirox Olamine Market Size by Country (2019-2024)
9.4 Latin America Ciclopirox Olamine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ciclopirox Olamine Market Size (2019-2030)
10.2 Middle East & Africa Ciclopirox Olamine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ciclopirox Olamine Market Size by Country (2019-2024)
10.4 Middle East & Africa Ciclopirox Olamine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Ciclopirox Olamine Introduction
11.1.4 Bayer Revenue in Ciclopirox Olamine Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Apotex Corporation
11.2.1 Apotex Corporation Company Detail
11.2.2 Apotex Corporation Business Overview
11.2.3 Apotex Corporation Ciclopirox Olamine Introduction
11.2.4 Apotex Corporation Revenue in Ciclopirox Olamine Business (2019-2024)
11.2.5 Apotex Corporation Recent Development
11.3 Fougera (Sandoz)
11.3.1 Fougera (Sandoz) Company Detail
11.3.2 Fougera (Sandoz) Business Overview
11.3.3 Fougera (Sandoz) Ciclopirox Olamine Introduction
11.3.4 Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2019-2024)
11.3.5 Fougera (Sandoz) Recent Development
11.4 Medimetriks Pharmaceuticals
11.4.1 Medimetriks Pharmaceuticals Company Detail
11.4.2 Medimetriks Pharmaceuticals Business Overview
11.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Introduction
11.4.4 Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024)
11.4.5 Medimetriks Pharmaceuticals Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Detail
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Ciclopirox Olamine Introduction
11.5.4 Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Preferred Pharmaceuticals
11.6.1 Preferred Pharmaceuticals Company Detail
11.6.2 Preferred Pharmaceuticals Business Overview
11.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Introduction
11.6.4 Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024)
11.6.5 Preferred Pharmaceuticals Recent Development
11.7 Ingenus Pharmaceuticals
11.7.1 Ingenus Pharmaceuticals Company Detail
11.7.2 Ingenus Pharmaceuticals Business Overview
11.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Introduction
11.7.4 Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024)
11.7.5 Ingenus Pharmaceuticals Recent Development
11.8 Alvogen (CVC Capital Partners and Temasek )
11.8.1 Alvogen (CVC Capital Partners and Temasek ) Company Detail
11.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview
11.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Introduction
11.8.4 Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2019-2024)
11.8.5 Alvogen (CVC Capital Partners and Temasek ) Recent Development
11.9 Acella Pharmaceuticals
11.9.1 Acella Pharmaceuticals Company Detail
11.9.2 Acella Pharmaceuticals Business Overview
11.9.3 Acella Pharmaceuticals Ciclopirox Olamine Introduction
11.9.4 Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024)
11.9.5 Acella Pharmaceuticals Recent Development
11.10 Dr Marc's Manufacturing
11.10.1 Dr Marc's Manufacturing Company Detail
11.10.2 Dr Marc's Manufacturing Business Overview
11.10.3 Dr Marc's Manufacturing Ciclopirox Olamine Introduction
11.10.4 Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2019-2024)
11.10.5 Dr Marc's Manufacturing Recent Development
11.11 Paddock Laboratories (Perrigo)
11.11.1 Paddock Laboratories (Perrigo) Company Detail
11.11.2 Paddock Laboratories (Perrigo) Business Overview
11.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Introduction
11.11.4 Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2019-2024)
11.11.5 Paddock Laboratories (Perrigo) Recent Development
11.12 Sincerus
11.12.1 Sincerus Company Detail
11.12.2 Sincerus Business Overview
11.12.3 Sincerus Ciclopirox Olamine Introduction
11.12.4 Sincerus Revenue in Ciclopirox Olamine Business (2019-2024)
11.12.5 Sincerus Recent Development
11.13 Glades Pharmaceuticals (GSK)
11.13.1 Glades Pharmaceuticals (GSK) Company Detail
11.13.2 Glades Pharmaceuticals (GSK) Business Overview
11.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Introduction
11.13.4 Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2019-2024)
11.13.5 Glades Pharmaceuticals (GSK) Recent Development
11.14 Sterimax
11.14.1 Sterimax Company Detail
11.14.2 Sterimax Business Overview
11.14.3 Sterimax Ciclopirox Olamine Introduction
11.14.4 Sterimax Revenue in Ciclopirox Olamine Business (2019-2024)
11.14.5 Sterimax Recent Development
11.15 Guangzhou Kanghe Pharmaceutical
11.15.1 Guangzhou Kanghe Pharmaceutical Company Detail
11.15.2 Guangzhou Kanghe Pharmaceutical Business Overview
11.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Introduction
11.15.4 Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024)
11.15.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.16 Tianjin Lisheng Pharmaceutical
11.16.1 Tianjin Lisheng Pharmaceutical Company Detail
11.16.2 Tianjin Lisheng Pharmaceutical Business Overview
11.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Introduction
11.16.4 Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024)
11.16.5 Tianjin Lisheng Pharmaceutical Recent Development
11.17 Zhejiang Xianju Pharmaceutical
11.17.1 Zhejiang Xianju Pharmaceutical Company Detail
11.17.2 Zhejiang Xianju Pharmaceutical Business Overview
11.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Introduction
11.17.4 Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024)
11.17.5 Zhejiang Xianju Pharmaceutical Recent Development
11.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
11.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Introduction
11.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2019-2024)
11.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ciclopirox Olamine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cream Preparation
Table 3. Key Players of Temperture
Table 4. Key Players of Vaginal Suppository
Table 5. Global Ciclopirox Olamine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ciclopirox Olamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Ciclopirox Olamine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Ciclopirox Olamine Market Share by Region (2019-2024)
Table 9. Global Ciclopirox Olamine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Ciclopirox Olamine Market Share by Region (2025-2030)
Table 11. Ciclopirox Olamine Market Trends
Table 12. Ciclopirox Olamine Market Drivers
Table 13. Ciclopirox Olamine Market Challenges
Table 14. Ciclopirox Olamine Market Restraints
Table 15. Global Ciclopirox Olamine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Ciclopirox Olamine Market Share by Players (2019-2024)
Table 17. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclopirox Olamine as of 2023)
Table 18. Ranking of Global Top Ciclopirox Olamine Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Ciclopirox Olamine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ciclopirox Olamine Product Solution and Service
Table 22. Date of Enter into Ciclopirox Olamine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ciclopirox Olamine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Ciclopirox Olamine Revenue Market Share by Type (2019-2024)
Table 26. Global Ciclopirox Olamine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Ciclopirox Olamine Revenue Market Share by Type (2025-2030)
Table 28. Global Ciclopirox Olamine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Ciclopirox Olamine Revenue Market Share by Application (2019-2024)
Table 30. Global Ciclopirox Olamine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Ciclopirox Olamine Revenue Market Share by Application (2025-2030)
Table 32. North America Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Ciclopirox Olamine Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Ciclopirox Olamine Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Ciclopirox Olamine Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Ciclopirox Olamine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Ciclopirox Olamine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Ciclopirox Olamine Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Ciclopirox Olamine Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Ciclopirox Olamine Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Ciclopirox Olamine Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Ciclopirox Olamine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Ciclopirox Olamine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Ciclopirox Olamine Product
Table 50. Bayer Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Apotex Corporation Company Detail
Table 53. Apotex Corporation Business Overview
Table 54. Apotex Corporation Ciclopirox Olamine Product
Table 55. Apotex Corporation Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 56. Apotex Corporation Recent Development
Table 57. Fougera (Sandoz) Company Detail
Table 58. Fougera (Sandoz) Business Overview
Table 59. Fougera (Sandoz) Ciclopirox Olamine Product
Table 60. Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 61. Fougera (Sandoz) Recent Development
Table 62. Medimetriks Pharmaceuticals Company Detail
Table 63. Medimetriks Pharmaceuticals Business Overview
Table 64. Medimetriks Pharmaceuticals Ciclopirox Olamine Product
Table 65. Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 66. Medimetriks Pharmaceuticals Recent Development
Table 67. Taro Pharmaceuticals Company Detail
Table 68. Taro Pharmaceuticals Business Overview
Table 69. Taro Pharmaceuticals Ciclopirox Olamine Product
Table 70. Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 71. Taro Pharmaceuticals Recent Development
Table 72. Preferred Pharmaceuticals Company Detail
Table 73. Preferred Pharmaceuticals Business Overview
Table 74. Preferred Pharmaceuticals Ciclopirox Olamine Product
Table 75. Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 76. Preferred Pharmaceuticals Recent Development
Table 77. Ingenus Pharmaceuticals Company Detail
Table 78. Ingenus Pharmaceuticals Business Overview
Table 79. Ingenus Pharmaceuticals Ciclopirox Olamine Product
Table 80. Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 81. Ingenus Pharmaceuticals Recent Development
Table 82. Alvogen (CVC Capital Partners and Temasek ) Company Detail
Table 83. Alvogen (CVC Capital Partners and Temasek ) Business Overview
Table 84. Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Product
Table 85. Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 86. Alvogen (CVC Capital Partners and Temasek ) Recent Development
Table 87. Acella Pharmaceuticals Company Detail
Table 88. Acella Pharmaceuticals Business Overview
Table 89. Acella Pharmaceuticals Ciclopirox Olamine Product
Table 90. Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 91. Acella Pharmaceuticals Recent Development
Table 92. Dr Marc's Manufacturing Company Detail
Table 93. Dr Marc's Manufacturing Business Overview
Table 94. Dr Marc's Manufacturing Ciclopirox Olamine Product
Table 95. Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 96. Dr Marc's Manufacturing Recent Development
Table 97. Paddock Laboratories (Perrigo) Company Detail
Table 98. Paddock Laboratories (Perrigo) Business Overview
Table 99. Paddock Laboratories (Perrigo) Ciclopirox Olamine Product
Table 100. Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 101. Paddock Laboratories (Perrigo) Recent Development
Table 102. Sincerus Company Detail
Table 103. Sincerus Business Overview
Table 104. Sincerus Ciclopirox Olamine Product
Table 105. Sincerus Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 106. Sincerus Recent Development
Table 107. Glades Pharmaceuticals (GSK) Company Detail
Table 108. Glades Pharmaceuticals (GSK) Business Overview
Table 109. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Product
Table 110. Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 111. Glades Pharmaceuticals (GSK) Recent Development
Table 112. Sterimax Company Detail
Table 113. Sterimax Business Overview
Table 114. Sterimax Ciclopirox Olamine Product
Table 115. Sterimax Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 116. Sterimax Recent Development
Table 117. Guangzhou Kanghe Pharmaceutical Company Detail
Table 118. Guangzhou Kanghe Pharmaceutical Business Overview
Table 119. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Product
Table 120. Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 121. Guangzhou Kanghe Pharmaceutical Recent Development
Table 122. Tianjin Lisheng Pharmaceutical Company Detail
Table 123. Tianjin Lisheng Pharmaceutical Business Overview
Table 124. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Product
Table 125. Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 126. Tianjin Lisheng Pharmaceutical Recent Development
Table 127. Zhejiang Xianju Pharmaceutical Company Detail
Table 128. Zhejiang Xianju Pharmaceutical Business Overview
Table 129. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Product
Table 130. Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 131. Zhejiang Xianju Pharmaceutical Recent Development
Table 132. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
Table 133. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 134. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Product
Table 135. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2019-2024) & (US$ Million)
Table 136. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ciclopirox Olamine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ciclopirox Olamine Market Share by Type: 2023 VS 2030
Figure 3. Cream Preparation Features
Figure 4. Temperture Features
Figure 5. Vaginal Suppository Features
Figure 6. Global Ciclopirox Olamine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ciclopirox Olamine Market Share by Application: 2023 VS 2030
Figure 8. Ringworm Of The Body Case Studies
Figure 9. Athlete'S Foot Case Studies
Figure 10. Tinea Case Studies
Figure 11. Tinea Versicolor Case Studies
Figure 12. Candida Albicans Case Studies
Figure 13. Gynecological Anti-Infection Preparation Case Studies
Figure 14. Other Case Studies
Figure 15. Ciclopirox Olamine Report Years Considered
Figure 16. Global Ciclopirox Olamine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Ciclopirox Olamine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Ciclopirox Olamine Market Share by Region: 2023 VS 2030
Figure 19. Global Ciclopirox Olamine Market Share by Players in 2023
Figure 20. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclopirox Olamine as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Ciclopirox Olamine Revenue in 2023
Figure 22. North America Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Ciclopirox Olamine Market Share by Country (2019-2030)
Figure 24. United States Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Ciclopirox Olamine Market Share by Country (2019-2030)
Figure 28. Germany Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Ciclopirox Olamine Market Share by Region (2019-2030)
Figure 36. China Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Ciclopirox Olamine Market Share by Country (2019-2030)
Figure 44. Mexico Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Ciclopirox Olamine Market Share by Country (2019-2030)
Figure 48. Turkey Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Ciclopirox Olamine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 51. Apotex Corporation Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 52. Fougera (Sandoz) Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 53. Medimetriks Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 54. Taro Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 55. Preferred Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 56. Ingenus Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 57. Alvogen (CVC Capital Partners and Temasek ) Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 58. Acella Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 59. Dr Marc's Manufacturing Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 60. Paddock Laboratories (Perrigo) Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 61. Sincerus Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 62. Glades Pharmaceuticals (GSK) Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 63. Sterimax Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 64. Guangzhou Kanghe Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 65. Tianjin Lisheng Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 66. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 67. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Ciclopirox Olamine Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
